Sat.Apr 18, 2020 - Fri.Apr 24, 2020

article thumbnail

Herd immunity won’t stop the outbreak: 3 Dangerous Covid-19 Myths

Find Me Cure

The spread of misinformation about Covid-19 can only be parallelled by the spread of the virus itself. This would all be in good humour (like the jokes about fighting the virus with alcohol) if it was not so detrimental to many people’s health and mental wellbeing. . Here at FindMeCure we have always been careful not to present hypotheses as facts and to spread awareness rather than myths and conspiracy theories.

article thumbnail

The Language of “Recovery” in the Age of COVID-19

Eye on FDA

There have been many parallels drawn between this pandemic and the AIDS pandemic that began in 1981. And in fact while many obvious differences exist there are many valid comparisons. Moreover, there are some common threads that run through crises involving a communicable disease and here were a few from this writer back in February 2020. But as many turn their attention to a “recovery” phase for this pandemic, there are also some lessons learned from the experience of HIV/AIDS that

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Trial Layoffs Have Begun - Covid19 Update

ECRG Media's Clinical Research Podcast

Clinical Trial Layoffs Have Begun - COVID 19 Update Layoffs are finally here for the Clinical Trials Industry, many people thought it wouldnt happen but it has to happen for CROs to stay in business. Find out more in this deep dive into the first layoffs and changes that have hit the industry. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: »

article thumbnail

Will you change your supply chain to benefit from a VAT and duty free importation into Belgium?

Pharma Business Blog

As an effort to limit the impact of COVID-19, the Belgian government has introduced a temporary relief measure whereby certain goods imported into Belgium can benefit from a VAT and duty exemption. A key condition to benefit from said exemption entails the importation by a so-called recognized healthcare institution (almost all Belgian hospitals qualify as such an institution).

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

IQVIA COVID-19 April briefing: A deep dive on impacts for UK&I pharma + biotech

pharmaphorum

Overview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications for the healthcare ecosystem. In the global effort to proactively fight COVID-19, the webinar series has been designed to: •Provide some areas which pharma and biotech companies may wish to consider around the COVID-19 outbreak, in order to help guide our community through uncertain times •Share key healthcare impact learnings from those countries that are ahead in the COVID-19 curve •Lo

Genome 40
article thumbnail

Frame Therapeutics and eTheRNA immunotherapies NV open a new research collaboration to develop mRNA cancer vaccines against immunogenic neoantigens

Drug Discovery Today

Amsterdam (The Netherlands) and Niel (Belgium) April 22, 2020 Frame Therapeutics, a new biotechnology company focused on the development of neoantigen-based cancer vaccines, today announced that they have forged a research collaboration with eTheRNA immunotherapies NV, a clinical-stage company developing vaccines and immunotherapies from its proprietary mRNA TriMix platform.

More Trending

article thumbnail

Pharmacovigilance at Glance :- Safety Monitoring

Pharma Tutor

AUTHORS : Girjesh Vishwakarma*, Dr.Surendra Kumar Jain . Sagar Institute of Research & Technology - Pharmacy. Opp. Sagar Estate, Ayodhya By Pass Road, Bhopal - 462 041 (MP). Gv1448@gmail.com. ABSTRACT : . Now a day’s usage of drugs has been increasing day by day and pharmaceutical companies are developing new drug products and humans begin taking more and effective drugs also as investigational drugs.

article thumbnail

Counterfeit Chloroquine Doesn’t Treat Covid-19; Does Genuine Chloroquine?

Pharmacy Checkers

Sad as it may be, it should not surprise anyone that hucksters are peddling coronavirus quackery on the Internet related to the treatment of Covid-19. Whether it be through marketing a fake test, medical advice or shoddy personal protective equipment, bad people are trying to profit off this crisis. Recent research shows that rogue websites are selling fake chloroquine phosphate or hydroxychloroquine, taking advantage of the promotion of these antimalarials as possible treatments for the novel c

article thumbnail

XenoGesis wins prestigious Queen’s Award for Enterprise in recognition of export growth

Drug Discovery Today

Nottingham-based leading independent DMPK provider, XenoGesis, has been awarded the prestigious Queen’s Award for Enterprise, International Trade, in recognition of its outstanding year-on-year export growth.

40
article thumbnail

Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells

Drug Discovery Today

Cambridge, UK, and Brisbane, CA, 21 April 2020 Mogrify Ltd (Mogrify®), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, and Sangamo Therapeutics (Sangamo) (Nasdaq: SGMO), a genomic medicine company, today announced that they have executed a collaboration and exclusive license agreement for Sangamo to develop allogeneic cell therapies from Mogrify’s proprietary induced pluripotent stem cells (iPSCs) and embryonic stem cells

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Goodfellow’s ‘Mr. Material’ app tests scientific knowledge during lockdown

Drug Discovery Today

Looking for new ways to test your knowledge during the lockdown? Leading global supplier of research materials, Goodfellow, has recently updated its Mr. Material game, a free educational app which tests the extent of your periodic table knowledge.

article thumbnail

Vaccines Manufacturing and Innovation Centre Fast Tracked as Works Progress at Harwell Campus

Drug Discovery Today

Construction of the UK’s New Vaccines Centre by Glencar Construction Starts Well Ahead of Schedule as Timelines are Fast Tracked Due to Covid-19

article thumbnail

Independent SMO Panthera Biopartners continues to expand its network of clinical trial sites

Drug Discovery Today

Panthera’s second clinical trial site in the UK, in North Manchester is open for business.

article thumbnail

Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer

Drug Discovery Today

Only PARP inhibitor to improve overall survival vs.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.